Skip to main content
Top
Published in: European Radiology 7/2023

18-04-2023 | Eclampsia | Commentary

Commentary: magnetic resonance spectroscopy and liquid chromatography-mass spectrometry metabolomics study may differentiate pre-eclampsia from gestational hypertension

Author: Ante Zhu

Published in: European Radiology | Issue 7/2023

Login to get access

Excerpt

Pre-eclampsia is a serious pregnancy complication characterized by the new onset of hypertension, proteinuria that indicates kidney damage, or significant dysfunction of other organs. It typically develops after 20 weeks of gestation and affects about 4.6% of all pregnancies worldwide. Mothers may develop headaches, visual deficits, acute renal failure, liver injury, pulmonary edema, stroke, etc. In the most severe cases, seizures (eclampsia) might appear. Pre-eclampsia and eclampsia cause 14% of maternal deaths each year, or about 75,000 mothers worldwide [1]. Pre-eclampsia may also affect the placenta, leading to placental abruption, preterm birth, fetal growth restriction, pregnancy loss, or stillbirth. …
Literature
Metadata
Title
Commentary: magnetic resonance spectroscopy and liquid chromatography-mass spectrometry metabolomics study may differentiate pre-eclampsia from gestational hypertension
Author
Ante Zhu
Publication date
18-04-2023
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 7/2023
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-09638-5

Other articles of this Issue 7/2023

European Radiology 7/2023 Go to the issue